---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-109825"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2024-12-17T23:59:59+00:00"
generated_at: "2026-05-29T02:15:41.777194+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Oramed recieves $13.2M from Scilex, slashing Tranche A principal to $7.7M

## Summary
- Scilex paid ~$13.2M on Dec 13, 2024, satisfying the $15M installment due Dec 21.
- Combined with prior payments, $94.2M of original $101.9M Tranche A Note has been repaid or refinanced.
- Remaining Scilex debt to Oramed: $7.675M (Tranche A) and $25M (Tranche B Notes).
- Payment stems from September 2023 securities purchase agreement and subsequent October 2024 refinancing.

## SEC filing metadata
- accession: 0001213900-24-109825
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2024-12-17T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390024109825/0001213900-24-109825-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390024109825/ea0225149-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-109825
- JSON: https://secwatch.observer/filing/0001213900-24-109825.json
- Plain text: https://secwatch.observer/filing/0001213900-24-109825.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.